Clinicopathological and Prognostic Significance of MUC4 Expression in Cancers: Evidence from Meta-analysis

Overview

Journal Int J Clin Exp Med

Specialty General Medicine

Date 2015 Sep 18

PMID 26379819

Citations 19

Authors

Xing Huang

Xin Wang

Shi-Ming Lu

Chen Chen

Jie Wang

Yan-Yan Zheng

Bin-Hui Ren

Lin Xu

Affiliations

Soon will be listed here.

Abstract

Mucin4 (MUC4) is a secreted glycoprotein. Numerous studies had indicated that MUC4 was an attractive prognostic tumor biomarker. However, the results of different studies have been inconsistent. So we conducted this meta-analysis to explore the association between MUC4 expression and cancer prognosis. A systematically comprehensive search was performed through PubMed, EMBASE and CNKI (Chinese National Knowledge Infrastructure). Prognostic value of MUC4 expression in malignancy patients was evaluated by pooled hazard ratios (HRs) and their 95% confidence intervals (CIs). Meanwhile, pooled odds ratio (OR) with 95% CI was appropriate for the association between MUC4 expression and clinicopathological parameters. Eighteen studies including 1,933 patients were enrolled in this meta-analysis. Significant association was found between elevated MUC4 expression and poorer overall survival (OS) with pooled hazard ratio (HR) of 1.87 [95% confidence interval (CI): 1.58-2.23, P<0.001]. Significant associations were also detected in biliary tract carcinoma (HR: 2.41, 95% CI: 1.69-3.42, P<0.001), pancreatic cancer (HR: 2.01, 95% CI: 1.42-2.86, P<0.001) and colorectal cancer (HR: 1.73, 95% CI: 1.17-2.54, P=0.006). Moreover, combined odds ratio (OR) of MUC4 indicated that MUC4 overexpression was associated with tumor stage, tumor invasion and lymph node metastasis. Our results demonstrated that MUC4 may be exploited as a novel prognostic biomarker for cancer patients.

Citing Articles

Molecular genetic analysis of colorectal carcinoma with an aggressive extraintestinal immunohistochemical phenotype.

Hrudka J, Kalinova M, Fiserova H, Jelinkova K, Nikov A, Waldauf P Sci Rep. 2024; 14(1):22241.

PMID: 39333321 PMC: 11437151. DOI: 10.1038/s41598-024-72687-3.

Potential Cause-and-Effect Relationship between Gut Microbiota and Childhood Neuroblastoma: A Mendelian Randomization Analysis.

Chu J Indian J Pediatr. 2024; .

PMID: 38536652 DOI: 10.1007/s12098-024-05065-6.

MUC13 negatively regulates tight junction proteins and intestinal epithelial barrier integrity via protein kinase C.

Segui-Perez C, Stapels D, Ma Z, Su J, Passchier E, Westendorp B J Cell Sci. 2024; 137(5).

PMID: 38345099 PMC: 10984281. DOI: 10.1242/jcs.261468.

Genetic variants of MUC4 are associated with susceptibility to and mortality of colorectal cancer and exhibit synergistic effects with LDL-C levels.

Kwon M, Lee J, Kim E, Ko E, Ryu C, Cho H PLoS One. 2023; 18(6):e0287768.

PMID: 37384668 PMC: 10310026. DOI: 10.1371/journal.pone.0287768.

Radiomics models based on multi-sequence MRI for preoperative evaluation of MUC4 status in pancreatic ductal adenocarcinoma: a preliminary study.

Deng Y, Li Y, Wu J, Zhou T, Tang M, Chen Y Quant Imaging Med Surg. 2022; 12(11):5129-5139.

PMID: 36330180 PMC: 9622441. DOI: 10.21037/qims-22-112.

References

Higashi M, Yokoyama S, Yamamoto T, Goto Y, Kitazono I, Hiraki T . Mucin expression in endoscopic ultrasound-guided fine-needle aspiration specimens is a useful prognostic factor in pancreatic ductal adenocarcinoma. Pancreas. 2015; 44(5):728-34. PMC: 4464972. DOI: 10.1097/MPA.0000000000000362. View

Jepson S, Komatsu M, Haq B, Arango M, Huang D, Carraway C . Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways. Oncogene. 2002; 21(49):7524-32. DOI: 10.1038/sj.onc.1205970. View

Tierney J, Stewart L, Ghersi D, Burdett S, Sydes M . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007; 8:16. PMC: 1920534. DOI: 10.1186/1745-6215-8-16. View

Chauhan S, Singh A, Ruiz F, Johansson S, Jain M, Smith L . Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod Pathol. 2006; 19(10):1386-94. DOI: 10.1038/modpathol.3800646. View

Polyak K, Kato J, Solomon M, Sherr C, Massague J, Roberts J . p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 1994; 8(1):9-22. DOI: 10.1101/gad.8.1.9. View

Weed D, Gomez-Fernandez C, Yasin M, Hamilton-Nelson K, Rodriguez M, Zhang J . MUC4 and ErbB2 expression in squamous cell carcinoma of the upper aerodigestive tract: correlation with clinical outcomes. Laryngoscope. 2004; 114(8 Pt 2 Suppl 101):1-32. DOI: 10.1097/00005537-200408001-00001. View

Hamada T, Wakamatsu T, Miyahara M, Nagata S, Nomura M, Kamikawa Y . MUC4: a novel prognostic factor of oral squamous cell carcinoma. Int J Cancer. 2011; 130(8):1768-76. DOI: 10.1002/ijc.26187. View

Audie J, Tetaert D, Pigny P, Buisine M, Janin A, Aubert J . Mucin gene expression in the human endocervix. Hum Reprod. 1995; 10(1):98-102. DOI: 10.1093/humrep/10.1.98. View

Giuntoli 2nd R, Rodriguez G, Whitaker R, Dodge R, Voynow J . Mucin gene expression in ovarian cancers. Cancer Res. 1998; 58(23):5546-50. View

10.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010; 8(5):336-41. DOI: 10.1016/j.ijsu.2010.02.007. View

11.

Alos L, Lujan B, Castillo M, Nadal A, Carreras M, Caballero M . Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol. 2005; 29(6):806-13. DOI: 10.1097/01.pas.0000155856.84553.c9. View

12.

Streppel M, Vincent A, Mukherjee R, Campbell N, Chen S, Konstantopoulos K . Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon. Hum Pathol. 2012; 43(10):1755-63. PMC: 3547617. DOI: 10.1016/j.humpath.2012.01.005. View

13.

Kwon K, Ro J, Singhal N, Killen D, Sienko A, Allen T . MUC4 expression in non-small cell lung carcinomas: relationship to tumor histology and patient survival. Arch Pathol Lab Med. 2007; 131(4):593-8. DOI: 10.5858/2007-131-593-MEINCL. View

14.

Saitou M, Goto M, Horinouchi M, Tamada S, Nagata K, Hamada T . MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol. 2005; 58(8):845-52. PMC: 1770880. DOI: 10.1136/jcp.2004.023572. View

15.

Carraway 3rd K, Rossi E, Komatsu M, Huang D, Guy P, Carvajal M . An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling. J Biol Chem. 1999; 274(9):5263-6. DOI: 10.1074/jbc.274.9.5263. View

16.

Lee H, Cho M, Kim T . Prognostic significance of muc4 expression in gallbladder carcinoma. World J Surg Oncol. 2012; 10:224. PMC: 3500712. DOI: 10.1186/1477-7819-10-224. View

17.

Gipson I, Spurr-Michaud S, Moccia R, Zhan Q, Toribara N, Ho S . MUC4 and MUC5B transcripts are the prevalent mucin messenger ribonucleic acids of the human endocervix. Biol Reprod. 1998; 60(1):58-64. DOI: 10.1095/biolreprod60.1.58. View

18.

Tsutsumida H, Goto M, Kitajima S, Kubota I, Hirotsu Y, Wakimoto J . MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma. Lung Cancer. 2006; 55(2):195-203. DOI: 10.1016/j.lungcan.2006.10.013. View

19.

Chaturvedi P, Singh A, Batra S . Structure, evolution, and biology of the MUC4 mucin. FASEB J. 2007; 22(4):966-81. PMC: 2835492. DOI: 10.1096/fj.07-9673rev. View

20.

Westgaard A, Schjolberg A, Cvancarova M, Eide T, Clausen O, Gladhaug I . Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours. Histopathology. 2009; 54(3):337-47. PMC: 2680278. DOI: 10.1111/j.1365-2559.2009.03227.x. View